Literature DB >> 3079730

Lipopolysaccharide structures in Enterobacteriaceae, Pseudomonas aeruginosa, and Vibrio cholerae are immunologically related to Campylobacter spp.

G I Perez-Perez, J A Hopkins, M J Blaser.   

Abstract

To determine whether lipopolysaccharide (LPS) structures of Campylobacter species are immunologically related to those of 11 other gram-negative organisms, we immunoblotted from polyacrylamide gels the LPS of these strains with immune rabbit serum raised against six Campylobacter jejuni strains and two Campylobacter fetus strains. The LPS studied were from Salmonella minnesota wild type and Ra to Re mutants, Salmonella typhi, Escherichia coli, Yersinia enterocolitica, Vibrio cholerae, and Pseudomonas aeruginosa. None of the 11 LPS preparations was recognized by the eight antisera, but antisera to each of the Campylobacter strains recognized core determinants of some LPS preparations. Antiserum directed against the most serum-sensitive C. jejuni strain, 79-193, was the only antiserum sample that recognized core regions of the rough Salmonella mutants. In converse experiments, when LPS preparations from five Campylobacter strains were blotted with antiserum to Salmonella lipid A, recognition of core structures of each was shown; data from an enzyme-linked immunosorbent assay confirmed this result. In contrast, antiserum to Salmonella typhimurium Re LPS showed no reactivity. We conclude that LPS of Campylobacter strains share lipid A antigenic determinants with the core region of LPS of several other gram-negative organisms.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3079730      PMCID: PMC261087          DOI: 10.1128/iai.51.1.204-208.1986

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  18 in total

1.  Biochemical studies on lipopolysaccharides of Salmonella R mutants. 6. Investigations on the structure of the lipid A component.

Authors:  J Gmeiner; O Lüderitz; O Westphal
Journal:  Eur J Biochem       Date:  1969-01

2.  The sensitivity of smooth and rough gram-negative bacteria to the immune bactericidal reaction.

Authors:  L H Muschel; L J Larsen
Journal:  Proc Soc Exp Biol Med       Date:  1970-01

Review 3.  Immunochemistry of O and R antigens of Salmonella and related Enterobacteriaceae.

Authors:  O Lüderitz; A M Staub; O Westphal
Journal:  Bacteriol Rev       Date:  1966-03

4.  Structural relationship of Salmonella O and R antigens.

Authors:  O Lüderitz; C Galanos; H J Risse; E Ruschmann; S Schlecht; G Schmidt; H Schulte-Holthausen; R Wheat; O Westphal; J Schlosshardt
Journal:  Ann N Y Acad Sci       Date:  1966-06-30       Impact factor: 5.691

5.  Preparation and properties of antisera against the lipid-A component of bacterial lipopolysaccharides.

Authors:  C Galanos; O Lüderitz; O Westphal
Journal:  Eur J Biochem       Date:  1971-12-22

6.  Identification and characterization of Campylobacter jejuni outer membrane proteins.

Authors:  M J Blaser; J A Hopkins; R M Berka; M L Vasil; W L Wang
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

7.  Campylobacter jejuni outer membrane proteins are antigenic for humans.

Authors:  M J Blaser; J A Hopkins; M L Vasil
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

8.  Studies of Campylobacter jejuni in patients with inflammatory bowel disease.

Authors:  M J Blaser; D Hoverson; I G Ely; D J Duncan; W L Wang; W R Brown
Journal:  Gastroenterology       Date:  1984-01       Impact factor: 22.682

9.  Serological cross-reactions between Acinetobacter calcoaceticus and chlamydiae.

Authors:  H Brade; H Brunner
Journal:  J Clin Microbiol       Date:  1979-12       Impact factor: 5.948

10.  Morphological heterogeneity among Salmonella lipopolysaccharide chemotypes in silver-stained polyacrylamide gels.

Authors:  P J Hitchcock; T M Brown
Journal:  J Bacteriol       Date:  1983-04       Impact factor: 3.490

View more
  9 in total

1.  Pathogenesis of Campylobacter fetus infections. Failure of encapsulated Campylobacter fetus to bind C3b explains serum and phagocytosis resistance.

Authors:  M J Blaser; P F Smith; J E Repine; K A Joiner
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

2.  Antigenicity of Campylobacter jejuni flagella.

Authors:  M J Blaser; J A Hopkins; G I Perez-Perez; H J Cody; D G Newell
Journal:  Infect Immun       Date:  1986-07       Impact factor: 3.441

3.  Conservation and diversity of Campylobacter pyloridis major antigens.

Authors:  G I Perez-Perez; M J Blaser
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

4.  Cross-reactive antigens shared by Pseudomonas aeruginosa, Helicobacter pylori, Campylobacter jejuni, and Haemophilus influenzae may cause false-positive titers of antibody to H. pylori.

Authors:  H K Johansen; A Nørgaard; L P Andersen; P Jensen; H Nielsen; N Høiby
Journal:  Clin Diagn Lab Immunol       Date:  1995-03

5.  Demonstration of lipopolysaccharide with O-polysaccharide chains among different heat-stable serotypes of Campylobacter jejuni by silver staining of polyacrylamide gels.

Authors:  D C Blake; R G Russell
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

6.  Structural analysis of lipopolysaccharides from Eikenella corrodens by use of murine monoclonal antibodies.

Authors:  T Kato; I Takazoe; K Okuda
Journal:  Infect Immun       Date:  1989-02       Impact factor: 3.441

7.  Biochemical characterization of Campylobacter fetus lipopolysaccharides.

Authors:  A P Moran; D T O'Malley; T U Kosunen; I M Helander
Journal:  Infect Immun       Date:  1994-09       Impact factor: 3.441

8.  Altering Microbiomes with Hydroxyapatite Nanoparticles: A Metagenomic Analysis.

Authors:  Vuk Uskoković; Victoria M Wu
Journal:  Materials (Basel)       Date:  2022-08-24       Impact factor: 3.748

9.  Helicobacter pylori and Clostridium difficile in cystic fibrosis patients.

Authors:  Jacob Yahav; Zmira Samra; Hannah Blau; Gabriel Dinari; Gabriel Chodick; Haim Shmuely
Journal:  Dig Dis Sci       Date:  2006-11-01       Impact factor: 3.487

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.